Matthias Hebben

Chief Tech/Sci/R&D Officer at LOGICBIO THERAPEUTICS, INC.

Consumer Services

Health Technology

Profile

Matthias Hebben is currently the Vice President & Head-Technology Development at LogicBio Therapeutics, Inc. Prior to this, he worked as the Director-AAV Technology & CMC Development at Genethon from 2013 to 2019 and as the Director-R&D Virology at Valneva SE from 2008 to 2013.
Hebben received his undergraduate degree from the University of Strasbourg and his doctorate from the University of Nice Sophia Antipolis.
He also received an undergraduate degree from Louis Pasteur University.

Matthias Hebben active positions

Companies	Position	Start
LOGICBIO THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2019-01-31

All active positions of Matthias Hebben

Former positions of Matthias Hebben

Companies	Position	End
Genethon Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.	Corporate Officer/Principal	2019-01-31
VALNEVA	Corporate Officer/Principal	2012-12-31

See the detail of Matthias Hebben's experience

Training of Matthias Hebben

University of Strasbourg	Undergraduate Degree
University of Nice Sophia Antipolis	Doctorate Degree
Louis Pasteur University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthias Hebben's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
VALNEVA	Health Technology

Private companies	2
Genethon Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.	Health Technology
LogicBio Therapeutics, Inc. LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.	Health Technology